e24310Background: Immunotherapy and Precision Medicine therapy have increased survival in a minority of cancer patients. Genomic biomarkers that select for high tumor responders are not widely impl... Click to show full abstract
e24310Background: Immunotherapy and Precision Medicine therapy have increased survival in a minority of cancer patients. Genomic biomarkers that select for high tumor responders are not widely impl...
               
Click one of the above tabs to view related content.